At Anantlife, we aim to be at the forefront of personalized medicine and genomics. Using latest genomics technologies, we are developing DNA based kits for disease risk assessment, drug interactions, fitness and food allergies In the US, there are approximately 106,000 deaths and 2.2 million serious events due to adverse reaction to drugs. Adverse reactions to drugs are responsible for up to 7% hospital admissions in the US. Slight variations in one’s own DNA can be predictive of potential adverse reactions or even potential efficacy of a drug, especially in psychiatric patients on anti-depressant drugs. At Anantlife, we want our clients to live healthier lives based on their own DNA. We aim to provide you with your own personal profile of drug interactions and identify risk of potential adverse reactions using latest developments in medicine and latest genomics technology. We can provide drug interaction within your comprehensive profile or as a separate service to our clients, depending on your individual needs. We are launching 8 cancer risk assessment kits in June 2016.